The GOLMePsA study protocol: an investigator-initiated, double-blind, parallel-group, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomes

<p style="text-align:justify;"> Psoriatic arthritis (PsA) is a chronic inflammatory arthritis which impacts significantly on the quality of life and work capacity of affected individuals. Recent evidence has shown that early control of inflammation in PsA leads to improved long-term...

詳細記述

書誌詳細
主要な著者: De Marco, G, Helliwell, P, McGonagle, D, Emery, P, Coates, L, Hensor, E, Marzo-Ortega, H
フォーマット: Journal article
言語:English
出版事項: BioMed Central 2017